Over the course of this series, we have examined how supply chain fragmentation, complexity, predictive models, and distributed partnerships are...

This blog post was written by BrainXell. An industry-leading producer of neurons and glia advancing neuroscience research and partnering with over...

In a landmark move toward modernizing nonclinical drug evaluation, the FDA recently issued new draft guidance that identifies specific product...

In the first three installments of this series, we explored the shifts redefining pharmaceutical development and manufacturing (PharmDev): supply...

In the first two installments of this series, we explored 2 major reasons why pharmaceutical development and manufacturing (PharmDev) is being...

In the first installment of this series, we explored the Resilience Pivot — why pharmaceutical development and manufacturing (PharmDev) is moving...

This blog post was written by FUJIFILM Corporation, a global contract research organization (CRO) providing drug discovery and preclinical services...

As we kick off 2026, the era of predictable, cost-optimized manufacturing has largely been replaced by one of geopolitical shifts...

In a recent article that appeared in the San Diego Union Tribune, Matt McLoughlin, Senior VP Compliance and Category Management at Scientist.com...

This blog post was written by Applied Pathology Systems (APS). Based in Massachusetts, Applied Pathology Systems (APS) is a premier...